Valuation: Terumo Corporation

Market Cap 3,410B 21.75B 18.9B 17.65B 16.2B 30.55B 2,073B 31.08B 208B 81.49B 1,034B 81.69B 79.88B P/E 2027 *
20.1x
P/E 2028 * 18x
Enterprise Value 3,470B 22.13B 19.24B 17.96B 16.49B 31.09B 2,110B 31.63B 212B 82.94B 1,052B 83.14B 81.3B EV / Sales 2027 *
2.79x
EV / Sales 2028 * 2.56x
Free-Float
97.07%
Yield 2027 *
1.56%
Yield 2028 * 1.74%
1 day+0.50%
1 week+1.49%
Current month-0.04%
1 month+1.29%
3 months+18.70%
6 months+14.97%
Current year+2.33%
1 week 2,253
Extreme 2253
2,459
1 month 2,133
Extreme 2133
2,459
Current year 1,900
Extreme 1900
2,463
1 year 1,900
Extreme 1900
2,818
3 years 1,856
Extreme 1856
3,182
5 years 1,708
Extreme 1708
3,182
10 years 955
Extreme 955
3,182
Manager TitleAgeSince
Chief Executive Officer 62 31/03/2024
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 68 31/03/2022
Director/Board Member 63 20/06/2019
Director/Board Member 75 24/06/2020
Change 5-day change 1-year change 3-year change Capi.($)
+0.50%+1.49%-8.71%+5.81% 21.75B
+1.34%+2.52%-15.85%-0.39% 185B
+1.51%+2.92%-2.98%+2.59% 111B
-0.95%-0.89%+6.94%+61.15% 60B
+2.63%+9.46%+43.51%+59.34% 53.9B
+2.77%+7.10%-3.49%-36.65% 46.9B
+3.03%+1.94% - - 34.22B
+4.63%+19.00%+10.13%-28.48% 32.95B
+2.05%+5.04%+45.42%-5.89% 24.49B
+1.86%+6.52%+2.54%+3.17% 22.67B
Average +1.94%+4.93%+8.61%+6.74% 59.32B
Weighted average by Cap. +1.67%+3.73%+1.15%+8.01%

Financials

2027 *2028 *
Net sales 1,244B 7.94B 6.9B 6.44B 5.91B 11.15B 757B 11.34B 75.94B 29.74B 377B 29.82B 29.16B 1,323B 8.44B 7.33B 6.85B 6.29B 11.85B 804B 12.06B 80.74B 31.62B 401B 31.7B 31B
Net income 170B 1.08B 940M 878M 806M 1.52B 103B 1.55B 10.35B 4.05B 51.41B 4.06B 3.97B 189B 1.21B 1.05B 980M 899M 1.7B 115B 1.73B 11.55B 4.52B 57.39B 4.54B 4.43B
Net Debt 60.46B 386M 335M 313M 287M 542M 36.75B 551M 3.69B 1.44B 18.33B 1.45B 1.42B -22.97B -147M -127M -119M -109M -206M -13.97B -209M -1.4B -549M -6.97B -550M -538M
Logo Terumo Corporation
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
Employees
30,591
Date Price Change Volume
04/08/26 JP¥2,323.00 +0.50% 2,875,800
03/08/26 JP¥2,311.50 -0.54% 3,619,300
31/07/26 JP¥2,324.00 -3.79% 5,158,600
30/07/26 JP¥2,415.50 +1.39% 4,730,200
29/07/26 JP¥2,382.50 +4.08% 6,546,900
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
2,311.50JPY
Average target price
3,048.46JPY
Spread / Average Target
+31.88%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4543 Stock